NISA INVESTMENT ADVISORS, LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 145 filers reported holding CTI BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$0
-100.0%
1000.0%0.00%–
Q4 2022$1–100–0.00%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q4 2022.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders